Related Experiment Videos
The nature of multiple sclerosis
Charles M Poser1, Vesna V Brinar
1Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. cposer@bidmc.harvard.edu
Clinical Neurology and Neurosurgery
|June 5, 2004
Summary
Multiple sclerosis (MS) and disseminated encephalomyelitis (DEM) are distinct neurological conditions. A proposed classification separates MS variants from DEM types, emphasizing differing pathological characteristics and genetic influences.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) is a progressive neurological disease characterized by relapses and remissions, leading to permanent nervous system damage.
- The classification of MS and related conditions like Schilder's, Marburg's, and Baló's diseases has been debated, particularly concerning their pathological hallmarks.
- Devic's disease, or neuromyelitis optica (NMO), and its variants are often distinguished from MS, despite some overlapping clinical presentations.
Discussion:
- The unique, sharp-edged plaque is a pathognomonic feature of MS and is also observed in its variants, differentiating them from other demyelinating diseases.
- Neuromyelitis optica (NMO) and disseminated encephalomyelitis (DEM) represent distinct disease entities from MS, with differing pathological characteristics.
- Genetic factors play a crucial role in disease pathogenesis and presentation, as evidenced by studies in Japanese patients and marmosets with experimental autoimmune encephalomyelitis (EAE).
Key Insights:
- MS and DEM are not variants of the same condition, despite potential shared pathogenetic mechanisms.
- The sharp-edged plaque is a critical pathological marker for MS and its variants.
- Genetic endowment significantly influences disease manifestation and progression in demyelinating disorders.
Outlook:
- A revised classification is proposed to clearly delineate MS from DEM and its subtypes.
- Further research into the genetic underpinnings of demyelinating diseases will refine diagnostic criteria and therapeutic strategies.
- Distinguishing between MS and DEM is crucial for accurate diagnosis, prognosis, and targeted treatment approaches.